3
Participants
Start Date
March 8, 2018
Primary Completion Date
November 30, 2019
Study Completion Date
November 30, 2019
PMD-200
"the patients will be monitored by PMD-200. The technology consists of measurements of a number of nociception-related physiological parameters that corresponds with the autonomic nervous system's response to noxious stimuli, and using the company's proprietary algorithms, 'translating' these measurements into an index that represents the nociceptive response, the NoL™ (Nociception Level) Index. The NoL index is a relative index from 0 to 100, while 0 is no pain/nociception and 100 is extreme pain/nociception."
EEG monitor
An EEG device will be connected to the patient and display the Spectral Edge Frequency (SEF) signals and values on the subject monitor.
Galil Medical Center, Nahariya
Lead Sponsor
Medasense Biometrics Ltd
OTHER